BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 14565855)

  • 21. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis.
    Napoli J; Prentice D; Niinami C; Bishop GA; Desmond P; McCaughan GW
    Hepatology; 1997 Sep; 26(3):624-33. PubMed ID: 9303492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
    Camino AM; Atorrasagasti C; Maccio D; Prada F; Salvatierra E; Rizzo M; Alaniz L; Aquino JB; Podhajcer OL; Silva M; Mazzolini G
    J Gene Med; 2008 Sep; 10(9):993-1004. PubMed ID: 18615449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. meso-dihydroguaiaretic acid from Machilus thunbergii down-regulates TGF-beta1 gene expression in activated hepatic stellate cells via inhibition of AP-1 activity.
    Park EY; Shin SM; Ma CJ; Kim YC; Kim SG
    Planta Med; 2005 May; 71(5):393-8. PubMed ID: 15931574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.
    Kuriyama S; Yokoyama F; Inoue H; Takano J; Ogawa M; Kita Y; Yoshiji H; Deguchi A; Kimura Y; Himoto T; Yoneyama H; Kurokohchi K; Masaki T; Uchida N; Watanabe S
    Int J Mol Med; 2007 Feb; 19(2):317-24. PubMed ID: 17203207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia.
    Grasl-Kraupp B; Rossmanith W; Ruttkay-Nedecky B; Müllauer L; Kammerer B; Bursch W; Schulte-Hermann R
    Hepatology; 1998 Sep; 28(3):717-26. PubMed ID: 9731564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
    Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
    Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
    Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.
    Hui AY; Dannenberg AJ; Sung JJ; Subbaramaiah K; Du B; Olinga P; Friedman SL
    J Hepatol; 2004 Aug; 41(2):251-8. PubMed ID: 15288474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].
    Li Q; Zhou X; Yu J; Qian W; Xu KS
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1273-8. PubMed ID: 18844103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
    Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
    J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
    Kim MY; Baik SK; Jang YO; Suk KT; Kim JW; Kim HS; Cho MY; Choi SJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
    Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
    J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis.
    Kim KH; Kim HC; Hwang MY; Oh HK; Lee TS; Chang YC; Song HJ; Won NH; Park KK
    Biochem Biophys Res Commun; 2006 May; 343(4):1072-8. PubMed ID: 16579972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture.
    Breitkopf K; Lahme B; Tag CG; Gressner AM
    Hepatology; 2001 Feb; 33(2):387-96. PubMed ID: 11172340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of interferon gamma treatment on expression of TGF-beta1 and its receptors in liver fibrosis of mice with schistosomiasis japonica].
    Zhang BB; Jiao YW; Cai WM; Tao J; Liu RH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Dec; 22(6):340-3. PubMed ID: 15830858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased TGF-beta1 in the lungs of asbestos-exposed rats and mice: reduced expression in TNF-alpha receptor knockout mice.
    Liu JY; Brody AR
    J Environ Pathol Toxicol Oncol; 2001; 20(2):97-108. PubMed ID: 11394717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
    Kao YH; Chen CL; Jawan B; Chung YH; Sun CK; Kuo SM; Hu TH; Lin YC; Chan HH; Cheng KH; Wu DC; Goto S; Cheng YF; Chao D; Tai MH
    J Hepatol; 2010 Jan; 52(1):96-105. PubMed ID: 19913322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat.
    Saperstein LA; Jirtle RL; Farouk M; Thompson HJ; Chung KS; Meyers WC
    Hepatology; 1994 Feb; 19(2):412-7. PubMed ID: 8294098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.
    Bataller R; Gäbele E; Parsons CJ; Morris T; Yang L; Schoonhoven R; Brenner DA; Rippe RA
    Hepatology; 2005 May; 41(5):1046-55. PubMed ID: 15841463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.
    Weng H; Mertens PR; Gressner AM; Dooley S
    J Hepatol; 2007 Feb; 46(2):295-303. PubMed ID: 17125875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.